As a result of the developments in genetic and molecular biology, great progress has been made in reproductive health techniques. The preimplantation genetic diagnosis method, which is one of the best advances in the medical world, arouses great excitement.
With this method, embryos created in IVF laboratories can be tested in genetic laboratories before they are placed in the mother’s womb. Thus, the risk of transferring cells with genetic diseases and low chance of adherence can be eliminated.
In our age, genetic diagnosis methods provide the opportunity to detect diseased embryos and to select disease-free embryos. Thanks to the PGD method, healthy babies can be born with embryos with normal genetic structure.
Among the genetic diseases of preimplantation genetic diagnosis method, “thalassemia” is one of the most common diseases in our country. Apart from thalassemia, the transmission of sickle cell anemia, familial breast cancer, cystic fibrosis, fragile-x syndrome and many other genetic diseases to the unborn baby can be prevented.
There must be some reasons for this method to be applied to people. PGD method can be applied in families with genetic disease and risk of transmitting a hereditary disease to the unborn child, and many similar factors.
In addition, this method is also used in the absence of unbound sperm when the testicular canal of men is blocked.
During the IVF process, embryos are obtained by combining the egg taken from the mother and the sperm taken from the father under laboratory conditions. One cell is removed from the obtained embryo and the cells are examined for genetic diseases. Healthy embryos that do not carry the risk of the disease are separated and transferred to the expectant mother.